Phagocytes: Frontline Defenders of Innate Immunity

What Are Phagocytes?

Phagocytes are leukocytes specialized in engulfing and destroying pathogens, dead cells, and debris. They are central to innate immunity and bridge to adaptive immunity.

Major Phagocyte Types

Cell	Origin	Location	Key Features
Neutrophils	Bone marrow	Blood (first responders), tissues (acute inflammation)	Short-lived (hrs–days), multilobed nucleus, granules (MPO, elastase), NETosis
Monocytes	Bone marrow	Blood (circulating precursors)	Differentiate into macrophages/DCs in tissue
Macrophages	Monocytes (mostly), yolk sac/fetal liver (tissue-resident)	All tissues (Kupffer, alveolar, microglia, splenic, peritoneal)	Long-lived, plastic (M1/M2), phagocytosis, cytokine production, antigen presentation
Dendritic cells (DCs)	Monocytes, lymphoid precursors	Skin, mucosa, lymphoid organs	Professional APCs; bridge innate→adaptive
Eosinophils	Bone marrow	Blood, mucosal tissues	Parasites, allergy; phagocytose immune complexes

Phagocytosis: Step-by-Step

1. Recognition: PRRs (TLRs, NLRs, CLRs, scavenger receptors) bind PAMPs/DAMPs; opsonins (IgG, C3b, MBL, CRP) enhance via FcγR, CR1/3.
2. Engulfment: Actin-driven pseudopod extension → phagosome formation.
3. Phagosome maturation: Fusion with early endosome → late endosome → lysosome → phagolysosome (acidic, hydrolytic enzymes).
4. Killing mechanisms:
   • Oxygen-dependent: NADPH oxidase (NOX2) → ROS (O₂⁻, H₂O₂, HOCl via MPO) – respiratory burst.
   • Oxygen-independent: Defensins, cathelicidins, lysozyme, proteases, low pH, nutrient deprivation.
5. Antigen presentation: Peptides loaded on MHC-II → CD4⁺ T cell activation (macrophages, DCs).
6. Resolution: Efferocytosis (clearance of apoptotic cells) – anti-inflammatory (TGF-β, IL-10).

Clinical Relevance

• CGD (Chronic Granulomatous Disease): NOX2 defect → recurrent catalase-positive infections, granulomas.
• Leukocyte adhesion deficiency: Impaired migration.
• Chediak-Higashi: Giant granules, defective killing.
• Macrophage activation syndrome (MAS) / HLH: Uncontrolled phagocyte activation.

Therapeutic Targeting

• G-CSF (neutrophilia), GM-CSF.
• Inhibitors: anti-inflammatory (targeting cytokines from macrophages).
• CAR-macrophages, trained immunity (BCG) – emerging.